Hemin Terminated Phase 2 Trials for Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00467610Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS